The Role of the FTO Gene in Reward System Activation in Obese and Healthy Subjects
NCT ID: NCT01863212
Last Updated: 2013-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
500 participants
INTERVENTIONAL
2010-09-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuronal Correlates of Priming on Goal-directed and Cue-dependent Behavior
NCT03735732
Hypothalamic Functional Magnetic Resonance Imaging (fMRI) Response to Nutrients
NCT00686608
The Effect of a Meal on Brain Activation in Reward Pathways
NCT01631045
Neural Mechanisms for Reducing Interference During Episodic Memory Formation
NCT05092100
The Effect of Neurofeedback on Eating Behaviour
NCT02148770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Risk allele carriers
Individuals homozygous for the risk allele (A/A) The interventions administrated to this group: 'Blood sampling for genetic analyse', 'Stroop test', 'fMRI'
Blood sampling for genetic analyse
Blood sampling are performed at the initiation visit in order to screen for allele variants
Stroop test
Selective attention test where subjects, in one minute, names the ink color of several words without naming the word itself.
fMRI
Functional Magnetic Resonance Imaging, performed to view brain activity
Non risk allele carriers
Individuals homozygous for the non-risk allele (T/T) The interventions administrated to this group: 'Blood sampling for genetic analyse', 'Stroop test', 'fMRI'
Blood sampling for genetic analyse
Blood sampling are performed at the initiation visit in order to screen for allele variants
Stroop test
Selective attention test where subjects, in one minute, names the ink color of several words without naming the word itself.
fMRI
Functional Magnetic Resonance Imaging, performed to view brain activity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling for genetic analyse
Blood sampling are performed at the initiation visit in order to screen for allele variants
Stroop test
Selective attention test where subjects, in one minute, names the ink color of several words without naming the word itself.
fMRI
Functional Magnetic Resonance Imaging, performed to view brain activity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No metabolic disorders/diseases
* Right handed
* Color vision
* Normal sleep-wake rhythm (eg. shift workers can not participate)
Exclusion Criteria
* Grandparents originating from country outside the Nordic area
* Metallic implants
18 Years
37 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Benedict, PhD
Role: PRINCIPAL_INVESTIGATOR
dep. Neuroscience, Uppsala University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uppsala University
Uppsala, Uppsala County, Sweden
dep. Neuroscience, Uppsala University
Uppsala, Uppsala County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Andreoli MF, De Francesco PN, Titova OE, Perello M, Schioth HB. Plasma LEAP2 concentration is associated with attention and cognitive responses to low-calorie food cues in men depending on body weight status. Physiol Behav. 2025 Nov 1;301:115049. doi: 10.1016/j.physbeh.2025.115049. Epub 2025 Aug 7.
Wiemerslage L, Islam R, van der Kamp C, Cao H, Olivo G, Ence-Eriksson F, Castillo S, Larsen AL, Bandstein M, Dahlberg LS, Perland E, Gustavsson V, Nilsson J, Vogel H, Schurmann A, Larsson EM, Rask-Andersen M, Benedict C, Schioth HB. A DNA methylation site within the KLF13 gene is associated with orexigenic processes based on neural responses and ghrelin levels. Int J Obes (Lond). 2017 Jun;41(6):990-994. doi: 10.1038/ijo.2017.43. Epub 2017 Feb 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSF008786
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.